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ABSTRAC T
A gene encoding the Tilapia mossambica (Oreochromis mossambicus) growth hormone (tiGH ) was isolated and
sequenced. The gene spans 5.6 kb, including 3.7 kb of 5 9 and 0.2 kb of 3 9 flanking sequences and a 1.7-kb
transcription unit comprised of six exons and five introns. The gene and the 5 9 flanking region contain sev-
eral potential binding sites for Pit-1, a key transcription activator of mammalian GH genes. One of these
( 2 57/ 2 42) is highly conserved in fish GH genes. It activates transcription in pituitary cells and binds Pit-1.
Transfection of luciferase reporter plasmids containing either the 2 3602/ 1 19 tiGH sequence or one of its 5 9
deletion mutants ( 2 2863/, 2 1292/, and 2 463/ 1 19) resulted in strong activity in Pit-1-producing rat pituitary
GC  cells. A dose-dependent activation of the tiGH promoter was achieved in nonpituitary fish EPC  and mon-
key C OS cells cotransfected with a rat Pit-1 expression vector, demonstrating the crucial role played by Pit-
1 as an activator of the tiGH gene. Fusion of the tiGH promoter with the b -galactosidase gene led to transient
expression specifically in the nervous system of microinjected zebrafish embryos. The activity of the tiGH pro-
moter in GC  and EPC  cells was strongly repressed by extending its 3 9 end from 1 19 to 1 40, a sequence in
which a Pit-1-binding site was identified using gel retardation assays. Point mutations of the site that sup-
pressed Pit-1 binding in vitro restored full tiGH promoter activity. Thus, a Pit-1-binding site located in the 5 9
untranslated region mediates Pit-1-dependent repression of the tiGH gene.
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INTRODUC TION
P ITU ITA RY GROW TH HO RM O NE (GH) is a single-chain polypep-tide of about 22 kDa that is essential for normal growth and
development of all vertebrates (Holly and Wass, 1989). In
salmonids, GH participates together with thyroid hormone in
seawater adaptation, which involves enhanced growth, body sil-
vering, and tolerance to increased osmolarity (Barron, 1986;
Miwa and Inui, 1985; Bolton et al., 1987; Sweeting and Mc-
Keown, 1987). With prolactin (Prl), placental lactogen, and so-
matolactin, GH constitutes a family of structurally and func-
tionally related proteins believed to have a common ancestral
origin (Moore et al., 1982; Miller and Eberhardt, 1983; Rand-
Weaver et al., 1992). Thus, they can provide an ideal model
system  for investigating the structure±function relations, evo-
lution, and regulation of gene expression.
Growth hormone has been studied extensively at the levels
of protein, mRNA, and genomic sequences in a variety of
species. The nucleotide sequence of GH genes has been deter-
mined from birds (Tanaka et al., 1992), mammals (Barta et al.,
1981; DeNoto et al., 1981; Gordon et al., 1983; Byrne et al.,
1987; Vize and Wells, 1987), and fishes (Agellon et al., 1988;
Johansen et al., 1989; Chiou et al., 1990; Ber and Daniel, 1992;
Zhu et al., 1992; Devlin, 1993; Du et al., 1993; Tang et al.,
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1993; Yowe and Epping, 1995). The primary transcript ranges
from 1631 nt to 4166 nt in length. Known bird and mammalian
GH genes consist of five exons, whereas fish GH genes con-
tain either five or six exons.
In vertebrates, the somatotroph cells of the anterior pituitary
gland constitute the major site of GH expression, suggesting
that the developmental mechanisms determining tissue-specific
expression of the genes have been conserved in the course of
evolution. In mammals, transcription of the GH gene requires
the interaction of the regulatory factor Pit-1, also called growth
hormone factor 1 (GHF-1), with two cis-acting elements within
the proximal promoter (review ed in Theill and Karin, 1993; An-
dersen and Rosenfeld, 1994). This transcriptional factor, a POU
homeodomain protein (Gehring et al., 1994), is also essential
for the expression of several other genes, including Prl (Man-
galam  et al., 1989). Recently, a Pit-1 cDNA has been cloned
from rainbow trout, and the functional binding of this fish Pit-
1 to the trout GH promoter has been demonstrated by DNase I
footprinting (Yamada et al., 1993). Furthermore, expression of
a chimeric rat Pit-1 containing the salmon Pit-1 POU domain
was shown to be effective in trans-activating the chinook
salmon Prl gene (Elsholtz et al., 1992), suggesting that both
the structure and the function of Pit-1 were highly conserved
during vertebrate evolution.
We cloned, sequenced, and characterized the genomic struc-
ture of the Tilapia mossambica (Oreochromis mossambicus )
GH (tiGH) gene. By transfection and cotransfection experi-
ments, we showed that the tiGH promoter is pituitary specific
and that this specificity is attributable to Pit-1. Microinjection
into zebrafish embryos leads to activation of the tiGH promoter
in the developing nervous system. In addition, we showed that
a Pit-1-binding site in the 5 9 -untranslated region (UTR) leads
to Pit-1 repression of the tiGH promoter.
MATERIALS AND M ETHODS
Library screening
The 400,000 plaques (recombinant Lambda GEM 11) of a
genomic library from tilapia (Sweenen et al., 1992) were
screened using as a probe the tiGH cDNA (Rentier-D elrue et
al., 1989) labeled by random priming (Random Priming DNA
Labeling Kit; Boehringer Mannheim, Germany) with [ a -32P]-
dCTP (3000 Ci/mM; Amersham ). Hybridization and washing
were carried out under stringent conditions. Positive clones
were purified by three additional screening cycles. After am-
plification (Grossberger, 1987), DNA was prepared and puri-
fied on a Quiagen ion-exchange column (Diagen, Hilden, Ger-
many) according to the manufacturer’ s instructions. Restriction
mapping and Southern blotting were performed using standard
procedures (Sambrook et al., 1989).
Plasmid constructs
The two contiguous SacI fragments (4.5 kb and 3.5 kb) re-
vealed by Southern blotting in the tiGH recombinant phage
were subcloned into the SacI site of the pGEM 3Z( 1 ) vector,
yielding pGEM4.5tiGH and pGEM3.5tiGH. The p0-Luc plas-
mid was prepared from the promoterless plasmid pBL-CAT6
(Boshart et al., 1992) by replacement of the chloramphenico l
acetyltransferase (CAT) gene with the luciferase (Luc) coding
region from pXP2 (Nordeen, 1988). The pCMV-Luc plasmid
has been described previously (Sekkali et al., 1994). The
pCMV- b Gal (MacGregor and Caskey, 1989) contains the E.
coli b -galactosidase reporter gene under the control of the cy-
tomegalovirus promoter/enhancer. The expression vector con-
taining the Rous sarcoma virus (RSV) promoter/ enhancer di-
recting expression of the rat Pit-1 has been described (Bodner
et al., 1988).
The p( 2 463/ 1 19)tiGH-Luc and p( 2 463/ 1 40)tiGh-Luc
plasm ids contain 463 bp of the tilapia GH 5 9 flanking region
and, respectively, 19 and 40 bp of the transcribed sequence
fused to the luciferase gene. The plasmids were prepared by
polymerase chain reaction (PCR) amplification of pGE-
M4.5tiGH using the 5 9 primer p-463 (5 9 -TTTCAGAATTCA-
GTTTAATGAC-3 9 ) and either p 1 19 (5 9 -GTGAGTCGGTG-
GTTCTGA-39 ) or p 1 40 (5 9 -TGCGGCTCAGATGATTATG-3 9 )
as a 3 9 primer. The amplified fragments were cloned by blunt-
end ligation into the BglII site of p0-Luc. The tiGH±Luc junc-
tions were confirmed by DNA sequencing (Sanger et al., 1977).
The BglII ( 2 1292/ 2 206) fragment of the tiGH 5 9 flanking
region was cloned into the BamHI/BglII sites of the
p( 2 463/ 1 19)tiGH-Luc expression vector, yielding p( 2 1292/
1 19)tiGH-Luc. Similarly, the PstI/SalI ( 2 3602/ 2 474) frag-
ment was inserted into the PstI/SalI sites of the p( 2 1292/
1 19)tiGH-Luc expression vector, yielding p( 2 3602/ 1 19)
tiGH-Luc. The p( 2 2863/ 1 19)tiGH-Luc expression vector was
constructed by HindIII digestion and religation of the
p( 2 3602/ 1 19)tiGH-Luc. Plasmid p0-LacZ was constructed by
inserting the XbaI fragment from pCMV b Gal, containing the
LacZ gene, into pGEM3 (Promega). The p( 2 463/ 1 19)tiGH -
LacZ vector was obtained by replacing the luciferase coding re-
gion (XhoI/KpnI fragm ent) from p( 2 463/ 1 19)tiGH-luc with
the XhoI/KpnI fragment from p0-LacZ containing the LacZ cod-
ing sequence. The pTk-Luc (Poncelet et al., 1996) contains the
luciferase reporter gene fused to the herpes simplex thymidine
kinase (Tk) promoter. The p2xtiGHF1-Tk-Luc was constructed
by cloning the tiGHF1 double-stranded synthetic oligonu-
cleotide (see the sequence below) into the BamHI site of the
pTk-Luc vector. The structure of all of the constructs was con-
firmed by restriction mapping. All these plasmids were pre-
pared by alkaline lysis and purified by a double centrifugation
in CsCl/ethidium bromide gradients (Sambrook et al., 1989).
Cell culture and transfection experiments
The GC cells were derived from a rat pituitary tumor and
express the endogenous GH gene (Tashjian et al., 1968). This
cell line was grown as monolayers at 37°C in Ham’ s F12 nu-
trient mixture supplemented with 10% fetal bovine serum (FBS)
and 1% penicillin±streptomycin. The EPC cells (Epithelioma
papulosum  cyprini), derived from carp epidermal herpes virus-
induced hyperplastic lesions (Fijan et al., 1983), were grown at
28°C in Dulbecco’ s Minimal Essential Medium  supplemented
with 10% FBS and 1% penicillin±streptom ycin. The COS-7
cells, derived from simian kidney, were grown at 37°C in the
same medium as the EPC cells. Neither COS-7 nor EPC cells
express endogenous GH gene.
For transfection assays, cells were harvested using trypsin-
EDTA and resuspended in the same culture medium at a con-
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centration of 15 3 106 cells/ml (12 3 106/800 m l). They were
mixed with 4 pmoles of purified plasm id DNA and transfected
by electroporation in 4-mm cuvettes using a single pulse (GC:
275 V, 1500 m f; EPC and COS: 250 V, 1500 m F) delivered by
a Cellject apparatus (Eurogentec, Seraing, Belgium). The trans-
fected cells were immediately transferred to three tissue culture
dishes (35 mm) and maintained in the same culture medium .
After 48 h, cells were harvested by scraping, washed three times
in cold 10 mM phosphate-buffere d saline, and resuspended in
200 m l of luciferase buffer (25 mM potassium  phosphate, pH
7.8; 8 mM MgCl2 , 1 mM EDTA, 1% BSA, 15% glycerol, and
1 mM DTT). After three cycles of freeze±thawing, the suspen-
sion was centrifuged, and the luciferase and b -galactosidase as-
says were performed. For the cotransfection experiments, EPC
and COS cells were transfected using the calcium phosphate
precipitation procedure as described by Inoue et al., (1990).
Luciferase and b -galactosidase assays
A total of 100 m l of cell extract was mixed with 80 m l of lu-
ciferase buffer. The tubes were placed in a Lumat LB 951 lu-
minometer (EG G. Berthold, Belgium), and the reaction was
initiated by injecting 100 m l of 0.3 mM luciferin and 0.8 mM
ATP. The peak light emission was recorded for 20 s. The b -
galactosidase activity was determined using 50 m l of extract as
described (Sambrook et al., 1989).
Zebrafish egg microinjection and 
b -galactosidase assay
All solutions for microinjection were prepared by diluting a
preparation of plasmid DNA (in 10 mM Tris HCl [pH 8.0] and
1 mM EDTA) to a final concentration of 40 ng/ m l in 10 mM
phosphate buffer pH 7.4, 150 mM NaCl, and 0.25% phenol red
to monitor the injection. Fertilized zebrafish eggs at the 1- to
2-cell stage were injected as described (Argenton et al., 1996a)
under a standard binocular microscope and incubated for 24 h
at 28.5°C. For tissue localization, embryos injected with the b -
galactosidase reporter plasmid, p( 2 463/ 1 19)tiGH- b gal, were
stained in situ for b -galactosidase activity as described (West-
erfield et al., 1992) except that the concentrations of
K4[Fe3(CN)6) and K3[Fe2(CN)6) were 5 mM, the concentration
of X-Gal (5-bromo-4-chlo ro-3-indolyl- b -D-galactoside) was
0.2%, and the embryos were stained for 16 to 24 h.
Extract preparation
Nuclear extracts from GC cells and tilapia and trout pitu-
itaries were prepared as described (Dignam et al., 1983). The
protein concentration in these extracts was determ ined using
the Bradford assay (1976) using BSA as a standard.
Oligonucleotides
The synthetic oligonucleotides were obtained from Euro-
gentec. The hGHF1 and tiGHF0 oligonucleotides contain, re-
spectively, the proximal Pit-1 binding site of the human GH
promoter (Lefevre et al., 1987) and the 5 9 untranslated Pit-1-
binding site of the tiGH gene. The tiGHF0m oligonucleotide
corresponds to the tiGHF0 oligonucleotide with a mutation in
the consensus Pit-1-binding site. The AP-1 oligonucleotide con-
tains the AP-1 site of the human collagenase promoter (Angel
et al., 1987). For each oligonucleotide, the sequence of one
strand is presented below:
hGHF1 5 9 -GATCCCATGCATAAATGTACACAG-3 9
tiGHF1 5 9 - T T C T C C T G A T G A A T T T A A A C A T C -
TAGTTTTCA-3 9
tiGHF0 5 9 -C C A C C G A C T C A C A T C A T A A T C A T C T -
GAGCCGCA-3 9
tiGHF0m 5 9 -C C A C CG A C T C A CA T C A T G AT C G A C T -
GAGCCGCA-3 9
AP-1 5 9 -AGCTTAAAGCATGAGTCAGACACCT-3 9
tiP1 5 9 -GATCCAGTCACCCTGCTCCTGCATAAC-
CAAACGACTGGAGG-3 9
Sp1 5 9 -CGACTGATCAGTTCCGCCCATTCTCCGC-
CCCAG
DR-4 5 9 -T C G A A G C T T C A G G T C A C A G G A G G T -
CAAGCT-3 9
Electrophoretic mobility shift assay
The synthetic double-stranded oligonucleotides (hGHF1 and
tiGHF0) were end-labeled using [ g -32P]-ATP and T4 polynu-
cleotide kinase. Electrophoretic mobility shift assays (EMSA)
were performed using 3 m g of GC cell or 15 m g of tilapia or
trout pituitary nuclear extract, 2 m g of poly(dI-dC), and 5000
to 10,000 cpm of 32P-labeled oligonucleotides in 20 mM Tris
HCl pH 7.9, 5 mM MgCl2, 100 mM KCl, 0.1 mM EDTA, 7.5%
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FIG. 1. Restriction map and DNA sequencing strategy for the SacI fragments of the tilapia mossambica GH recombinant clone.
Arrows indicate the direction of sequencing by the chain-terminati on method. T represents the TATA box, and PA represents the
polyadenylation signal. Open boxes indicate transcribed and untranslated regions, and hatched boxes indicate the coding regions.
Thin lines represent introns and flanking sequences.
FIG. 2. (Continued on next page) The complete nucleotide sequence of the tilapia mossambica growth hormone gene. Exons
are shown in uppercase letters; introns and flanking regions are in lowercase letters. The TATA box and the poly(A ) signal are
in boldface and underlined. The numbering is shown in the left margin and refers to the last nucleotide on the corresponding line.
The tsp is located at nucleotide 1 1, as assigned by analogy with the tGH2 gene of tilapia nilotica (Ber and Daniel, 1992). En-
coded amino acid residues, represented by one-letter code, are placed above the first nucleotide of each codon. The inverted re-
peat and the direct repeat observed in tiGH are represented by arrows and in boldface. Potential Pit-1-binding sites are repre-
sented in boldface. The tiGHF0 site is indicated. The sequence is available in the EMBL nucleotide sequence database under
Accession Number Y11732.
glycerol, and 1 mM dithiothreitol. The resulting DNA±protein
complexes were resolved by electrophoresis on a prerun 5%
polyacrylamide gel using 0.5 3 TBE as running buffer. In com-
petition experiments, we used a 100- or 200-fold molar excess
of unlabeled double-stranded oligonucleotides. For supershift
assays, a rabbit polyclonal IgG against the N-terminal part (aa
1±157) of bacterially expressed human Pit-1 (Pernasetti et al.,
1998) was used. The GC nuclear extract (3 m g) was incubated
for 1 h at 4°C with 1 m l of crude antiserum. Then, 0.5 ng of
32P-labeled oligonucleotide was added for 30 min at 4°C. The
samples were loaded on a 5% polyacrylamide gel and run in
0.5 3 TBE buffer.
RESULTS
Isolation, molecular cloning, and sequencing of
genomic clones
Screening of a genomic library from Oreochromis mossam-
bicus using the tiGH cDNA as a probe yielded 10 purified re-
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FIG. 2. (Continued )
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combinant phage. After restriction mapping and Southern blot
analysis (data not shown), it appeared that these clones were
identical and comprised two contiguous SacI fragments (4.5 and
3.5 kb) hybridizing with the probe. These fragm ents were in-
troduced into the pGEM vector and used to generate a library
of partial deletion subclones and sequenced using a bidirec-
tional strategy (Fig. 1).
Primary structure of tiGH
The two contiguous SacI fragments contained the whole cod-
ing region of the tiGH gene and about 3.7 kb of 5 9 flanking re-
gion. Alignment of the tiGH genomic sequence with a cDNA
encoding the GH from another tilapia species (Oreochromis
niloticus ) (Rentier-Delrue  et al., 1989) identified six exons and
five introns (Fig. 2). This general structure is similar to that of
the GH genes from rainbow trout (Agellon et al., 1988), At-
lantic salmon (Johansen et al., 1989; Male et al., 1992), tilapia
nilotica (Ber and Daniel, 1992, 1993) and the perciforme bar-
ramundi (Lates calcarifer ) (Yowe and Epping, 1995), which
have an extra intron compared with mammalian, chicken, and
carp GH genes. All five introns start with a GT and end with
an AG dinucleotide, in agreement with the classical consensus
splice sites (Mount, 1982).
The transcription start point (tsp) was assigned by sequence
alignment with the tilapia nilotica GH genes (Ber and Daniel,
1992, 1993). This tsp most likely is functional, as the adenine
residue is the central base of a CA(C/T) motif, shown to be es-
sential for eukaryotic gene tsp (Bucher, 1990). No other
CA(C/T) triplet was found between the TATA box and this tsp
(Fig. 2). From comparison with the structural part of the two
GH genes identified in tilapia nilotica (tGH1 and tGH2; Ber
and Daniel, 1992, 1993), the primary transcript encoded by the
tiGH gene seems to be identical to the tGH2 gene. Indeed, only
three substitutions and one insertion are observed between the
primary transcript of tiGH and tGH2. Two of the substitutions
are located in the second intron, and the third one is located in
the 3 9 -UTR. The primary transcript encoded by the tiGH gene
is 1666 nt long, which is 4 nt longer than the primary transcript
of tGH2. The length difference results from the insertion of an
additional CTGT repeat in the first intron (7 in tiGH and 6 in
tGH2).
Analysis of 3 9 and 5 9 flanking sequences of tiGH
At the 3 9 end, a putative polyadenylation signal, AATAAA
(Fig. 2) (Proudfoot and Brownlee, 1976), is located 178 bp
downstream from the stop codon. It is identical to the poly(A )
signal found in salmon, barramundi, chick, and mammals but
differs from the carp poly(A) signal, ATTAAA. In addition, the
length of the tiGH 3 9 -UTR is substantially the same as in mam-
mal, chicken, and barramundi GH genes (100±180 bp) (Miller
et al., 1980; Tanaka et al., 1992; Barta et al., 1981; DeNoto et
al., 1981; Gordon et al., 1983; Byrne et al., 1987; Vize and
Wells, 1987; Yowe and Epping, 1995) in contrast to 500 bp in
other fishes (Agellon et al., 1988; Johansen et al., 1989; Chiou
et al., 1990; Ber and Daniel, 1992; Zhu et al., 1992; Devlin,
1993; Du et al., 1993; Tang et al., 1993). The 5 9 flanking re-
gion of the tiGH gene contains the sequence TATAAA at a dis-
tance of 23 nt upstream from the transcription start point. Analy-
sis of the 3.7-kb sequence 5 9 upstream from the tsp of tiGH
reveals that only this putative TATA box is 100% conserved
in all the known GH genes.
As it was known that the pituitary-specific transcription of
the GH gene depends on the specific interaction of the nuclear
trans-acting protein GHF-1/Pit-1 (Bodner and Karin, 1987;
Nelson et al., 1988) with cis-acting elements located in the pro-
moter, a close search for possible Pit-1-binding sites within the
tiGH gene was carried out in the 5 9 flanking region. We found
several putative binding sequences for Pit-1 differing by no
more than 1 or 2 nt from the consensus 5 9 -A(A/T)(A/T)TAT-
NCAT-39 (Ingraham et al., 1988; Nelson et al., 1988) and with
the 5 9 end flanked by a very AT-rich region, a characteristic
found in other Pit-1-binding sites. Additional putative Pit-1
sites with different degeneracy were also observed in the struc-
tural part of the tiGH gene, located in introns I, II, IV, and V
and in the 5 9 -UTR. Comparison with the currently known fish
GH genes revealed one highly conserved sequence in the re-
gion flanking the TATA box (Fig. 3). This conserved sequence
( 2 56 GATGAATTTAAACAT 2 42) contains, in both orien-
tations, a potential binding site for Pit-1.
A sequence search for perfect and imperfect, direct, and in-
verted repeats revealed many such structures throughout the
gene. An imperfect inverted repeat at 2 628 bp seems to be
identical to that found in the tGH2 gene. On the other hand, a
67-bp imperfect direct repeat, separated by 55 bp, was found
at 2 2846 bp. The significance of these structures remains un-
known.
Trans-activation of tiGH promoter in 
rat pituitary cells
The functional role of the 5 9 flanking sequence of the tiGH
gene was studied by transient expression assays. To this pur-
pose, the activity of the 2 3602/ 1 19 region and of three pro-
gressive 5 9 deletion mutants fused to the luciferase gene were
tested in rat pituitary GC cells, which express both GH and Pit-
1, and in nonpituitary EPC or COS cells, which express nei-
ther GH nor Pit-1 (Fig. 4). The promoterless construct (p0-Luc)
and pCMV-Luc, which contains the promoter/enhancer of the
immediate early region of the human cytomegalovirus , were
used as negative and positive controls, respectively. The 3.6-
kb tiGH promoter region was able to drive high luciferase ac-
tivity in GC cells but not in EPC or in COS cells, in contrast
to the positive control pCMV-Luc, which displayed a high level
of expression in the three cell types.
Transfection of GC cells with 5 9 deletion mutants contain-
ing 3602, 2863, 1292, and 463 bp of the tiGH upstream region
in front of the Luc gene revealed two regulatory regions: a
strongly activating region downstream from 2 2863 and a
weakly inhibitory region between coordinates 2 2863 and
2 3602. All deletion mutants were transcriptionally active in
GC cells. The p( 2 2863/ 1 19)tiGH-Luc construct drove the
highest luciferase activity. Thus, the 2 463/ 1 19 proxim al pro-
moter, which contains six potential Pit-1-binding sites, is suf-
ficient to mediate high and specific trans-activation in Pit-1-
producing GC cells; and the 2 2863 to 2 463 region, which
contains additional potential Pit-1-binding sites, is required for
optim al responsiveness.
To confirm the binding of Pit-1 to the tiGH promoter, we
selected the most proximal ( 2 56/ 2 42) upstream  putative bind-
ing site for further investigation. Gel retardation experim ents
were carried out with an oligonucleotide corresponding to this
site (tiGHF1). Incubation of this probe (Fig. 5, lane 8) in the
presence of GC cell nuclear extracts generated two specific
complexes (lane 1; Pit-1 monomer and Pit-1 dimer). These com-
plexes were abolished in the presence of the specific competi-
tors tiGHF1 or tiP1 (lanes 2 and 3), the proximal Pit-1 site from
the tilapia prl promoter (Poncelet et al., 1996). In the presence
of nonspecific competitors (lanes 4 and 5), Sp1 or the thyroid
hormone response element DR-4, these two complexes were not
affected, whereas the slowly migrating nonspecific complex dis-
appeared completely. Addition of antibodies directed against Pit-
1 (lane 6), but not of preimmune serum (lane 7), completely
abolished the Pit-1 complexes. To test the transcriptional activ-
ity of this site, two copies of a tiGHF1 oligonucleotide were in-
serted upstream of the Tk promoter/luciferase reporter gene
(p2xtiGHF1-Tk-Luc). Transient transfection of this construct
into GC cells led to a twofold enhancement of transcription com-
pared with the control Tk-Luc plasmid (Fig. 6).
Activation of a tiGH-Luc fusion gene by 
coexpression of rat Pit-1 in nonpituitary cells
To investigate further whether Pit-1 is involved in tiGH gene
expression, we tested the ability of the rat Pit-1 to trans-acti-
vate the tiGH promoter in nonpituitary cell lines. As shown in
Figure 7, a dramatic (10- to 80-fold) stimulation of
p( 2 463/ 1 19)tiGH-Luc expression was observed in the pres-
ence of increasing amounts of pRSV-rPit-1 expression vector
compared with cotransfection with an equivalent molar amount
of the pRSV-CAT control vector.
Nervous system-specific expression of a 
tiGH-LacZ fusion gene in zebrafish embryos
As the tiGH proximal promoter is specifically active in rat
pituitary GC cells, we tested whether it would be able to drive
cell-specific transient expression of a reporter gene in devel-
oping zebrafish. An expression plasmid encoding the b -galac-
tosidase gene controlled by the 2 463/ 1 19 tiGH proximal pro-
moter was microinjected into zebrafish embryos at the one- to
two-cell stage (Argenton et al., 1996a). After 24 h of develop-
ment, embryos were stained for b -galactosidase activity with
the chromogenic substrate X-Gal and examined under the mi-
croscope for specific blue coloration. No staining was observed
in uninjected embryos (data not shown). In injected surviving
embryos, an intense nonspecific expression was observed in the
yolk sac endoderm surrounding the yolk of some embryos (see
Discussion). In addition, in 5 of the 30 survivors, blue staining
was detected specifically at the level of the developing nervous
system. The staining was restricted either to the midbrain±hind-
brain boundary (three embryos) (Fig. 8, arrow) or to the neural
tube (two embryos).
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FIG. 3. Alignment of the promoter regions from known fish GH genes. Asterisks represent nucleotides that are identical in all
eight sequences. Conserved promoter regions (A) are indicated. The tsp is designated 1 1. The putative TATA box is framed.
Gaps ( ? ) were introduced to obtain best alignment.
Transcriptional inhibition by a potential Pit-1 site
located downstream from the transcription start point
To investigate the biologic function of the potential Pit-
1-binding site tiGHF0 ( 1 20/ 1 30), located in the 5 9 -UTR of the
tiGH gene, tiGH reporter plasmids either containing (p( 2 463/
1 40)tiGH-Luc) or lacking (p( 2 463/ 1 19)tiGH-Luc) this site
were evaluated in transient expression assays (Fig. 9). Addition
of the sequences from 1 19 to 1 40 resulted in a fourfold de-
crease in activity in GC cells (Fig. 9A) and in EPC cells co-
transfected with pRSV-rPit-1 (Fig. 9B). When cells were grown
in the absence of serum, the presence of the sequence from 1 20
to 1 40 still decreased expression to the same extent (data not
shown), suggesting that the negative regulation by this Pit-1 site
is independent of extracellular bovine serum factors.
Because the length of the leader sequence is different in the
two constructs, the decreased expression of the p( 2 463/ 1 40)
tiGH-Luc construct could be secondary to decreased stability
of the corresponding mRNA. To address this question, we in-
troduced minimal point mutations in the potential Pit-1-bind-
ing site ( 1 23 ATAATCAT 1 31 to ATGATCG A) that would
be likely to block Pit-1 binding without affecting the resulting
mRNA size. This mutation in p( 2 463/ 1 40)tiGH-Luc resulted
in a fourfold increase in luciferase expression in GC cells (Fig.
9A) as well as in EPC cells cotransfected with pRSV-rPit-1
(Fig. 9B), restoring an activity similar to that of p( 2 463/
1 19)tiGH-Luc. Taken together, these data demonstrate that the
transient expression of the tiGH promoter is inhibited by a po-
tential Pit-1-binding site (tiGHF0) located in the 5 9 -UTR.
Pituitary proteins from rat, tilapia, and trout bind
specifically to potential Pit-1-binding  site tiGHF0
Electrophoretic mobility shift assays were perform ed to iden-
tify proteins interacting with the tiGHF0 inhibitory site. Incu-
bation of nuclear extracts derived from GC cells with a labeled
oligonucleotide, hGHF1, containing the proximal Pit-1-binding
site of the human GH promoter resulted in the formation of
three protein±DNA complexes (Ca, Cc, Cd) (Fig. 10A; lane 2).
Ca and Cc, previously shown to represent Pit-1 monomeric and
dimeric complexes, respectively (Lefevre et al., 1987), disap-
peared in the presence of a 200-fold molar excess of unlabeled
hGHF1 or tiGHF0 oligonucleotides (lanes 3 and 4), whereas
competition using tiGHF0m, an oligonucleotide mutated in the
Pit-1 consensus, was very weak (lane 5). Complex Cd was not
affected by unlabeled hGHF1 or tiGHF0 and thus was consid-
ered to be nonspecific. The unrelated AP-1 oligonucleotide
failed to compete for any of these complexes (lane 6).
When a labeled tiGHF0 oligonucleotide was incubated with
GC nuclear extracts, two complexes were detected having elec-
trophoretic mobilities identical to those of the Pit-1 complexes
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FIG. 4. Effects of 5 9 deletion mutants of the tilapia tiGH up-
stream region on transient luciferase expression. A . Schematic
representation of the tiGH promoter deletion mutants. Dots in-
dicate the putative Pit-1-binding sites B . The indicated reporter
plasmids plus 1 m g of pCMV- b gal, as an internal control, were
transfected into GC, EPC, and COS cells. After 2 days, cellu-
lar LUC activity was assayed and normalized to b -galactosi-
dase activity. Values are the means 6 SE from five indepen-
dent transfection experiments (except for EPC and COS cells,




Ca and Cc (lane 8). Addition of a 200-fold molar excess of un-
labeled tiGHF0 or hGHF1 oligonucleotides suppressed the two
complexes (lanes 9 and 11), whereas the tiGHF0m and AP1
oligonucleotides did not (lanes 10 and 12). Furthermore, addi-
tion of a Pit-1-specific antiserum resulted in supershift of the
complexes (lane 13). An additional complex (Cb), with an in-
termediate mobility, was considered to be nonspecific, as it was
unaffected by specific competitors or Pit-1 antibodies.
As the above results indicated that rat Pit-1 can bind to the
tilapia tiGHF0 site, we sought to determine whether tilapia pi-
tuitary cells contain a Pit-1-related factor able to bind to this
sequence. When a labeled tiGHF0 oligonucleotide was incu-
bated with tilapia pituitary extracts, three protein complexes ap-
peared (tiCa, tiCb, and tiCc) (Fig. 10B; lane 4). Formation of
these complexes was blocked by an excess of the human
hGHF1-binding site (lane 5). Because the weak tiCa complex
migrated at the same position as the strong, nonspecific com-
plex Cb obtained using GC cells (lanes 2 and 3), we assume
that the complexes tiCb and tiCc correspond to the monomeric
and dimeric Pit-1 forms, respectively. Both complexes migrated
more slowly when formed using tilapia (lane 4) or trout (lane
6) pituitary extracts, suggesting that the tilapia Pit-1-like pro-
tein is larger than its rat counterpart. Thus, the EMSA data in-
dicate that rat Pit-1 and a tilapia Pit-1-like protein specifically
interact with the potential tiGHF0 binding site located in the
5 9 -UTR of the tiGH gene.
DISC USSION
We describe the cloning, sequence analysis, and potential
cis-acting regulatory elements responsible for the pituitary spe-
cific-expression of the tiGH gene. Sequence analysis reveals a
high similarity to other known GH genes within the coding se-
quences but much smaller introns. The tiGH gene six-exon/ five-
intron structure confirms that the introduction of an additional
intron V into fish GH genes took place after the diversification
of teleosts but before the divergence of perciforms and salmoni-
forms (Chiou et al., 1990; Zhu et al., 1992; Hong and Schartl,
1993; Tang et al., 1993).
Analysis of the 5 9 flanking region of the tiGH gene revealed
two 39-bp inverted repeat sequences separated by 116 bp, form-
ing a transposon-like structure 628 nt upstream  from the tran-
scription start site. It is not related to the major repetitive DNA
family found in tilapia (Wright, 1989) nor to the highly repet-
itive POL III/SINE sequence present in the salmon genome
(Matsumoto et al., 1986). Furthermore, no effect on transcrip-
tional regulation was observed. We also found two 67-bp im-
perfect repeated sequences centered at 2 2846 and separated by
55 bp, without any significant homology with known tran-
scription factor binding sites. Deletion of this sequence weakly
but significantly increased the activity of tiGH in GC cells, sug-
gesting that it corresponds to a negative regulatory element.
In mammals, the promoter/enhancer regions of the GH gene
have been extensively characterized with respect to their tissue-
specific expression. Deletion analysis and DNase-I footprinting
experiments identified a DNA sequence motif that is required
for the pituitary-specific expression of the GH promoter. This
motif, 5 9 -A(A/T)(A/T)TATNCAT-3 9 , is the binding site for the
pituitary-specific factor Pit-1. This transcription factor belongs
to the POU homeodomain  proteins and is essential for the trans-
activation of the GH, b -TSH, Prl, and Pit-1 genes. A computer
search for such Pit-1-binding sites in the 5 9 flanking region of
the tiGH gene revealed several sequences identical to the con-
sensus Pit-1 core binding site or differing from it by only one
or two mismatches. All these potential binding sites are flanked
by a very AT-rich region, a characteristic found in other Pit-1-
binding sites. In light of the dependence of Pit-1 binding on nu-
cleotide changes (Elsholtz et al., 1990, Ono et al., 1995), some
of these sites may not be functional.
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FIG. 5. Gel retardation analysis of the tiGHF1 site. End-la-
beled tiGHF1, corresponding to the proximal putative upstream
Pit-1-binding site of the tiGH promoter, was incubated with 3
m g of GC nuclear extract (lane 1). For competition experiments,
a 100-fold molar excess of unlabeled oligonucleotide tiGHF1
(lane 2), tiP1 (lane 3), Sp1 (lane 4), or DR-4 (lane 5) was added
to the reaction mixture. Supershift assays were performed us-
ing 1 m l of crude antiserum raised against the N-terminal part
of the human Pit-1 protein (lane 6) or the corresponding preim-
mune serum (lane 7).
Transfection experiments in rat pituitary GC cells and in non-
pituitary EPC and COS cells using tiGH promoter/luciferase fu-
sion constructs resulted in high expression only in GC cells. A
5 9 deletion analysis led to the identification of a weak negative
region and a strong positive one in GC cells. The first one
( 2 2863/ 2 3602) contained the imperfect direct repeat men-
tioned above. Its possible involvem ent in negative regulation
remains to be explored. Within the second region, between
2 2863 and the tsp, the most proximal 463 bp are sufficient to
direct high-level pituitary-specific expression. Interestingly, six
potential Pit-1-binding sites were mapped in this region, and
we showed that the most proximal one ( 2 56/ 2 42), which is
highly conserved among the currently known fish GH genes
(Yamada et al., 1993; Argenton et al., 1996b), is functionally
active, as it specifically binds Pit-1 in gel retardation experi-
ments and confers activation to the Tk promoter in GC cells.
All the 5 9 deletion mutants tested were highly expressed only
in pituitary GC cells. The tiGH promoter was enhanced after
coexpression of rat Pit-1 in EPC (see Fig. 7) or COS cells (data
not shown), showing that Pit-1 might be responsible for the
trans-activation observed in GC cells in good correlation with
the high conservation of Pit-1 structure (Ono and Takayama,
1992) and functions (Elsholtz et al., 1992; Argenton et al.,
1996b) from fish to mammals.
Tissue-specific regulatory elements have been studied in
transiently transgenic fish. Rinder et al. (1992) confirmed that
the regulatory sequences from the zebrafish ependymin gene
(the predominant glycoprotein in the cerebrospinal fluid of fish,
thought to be involved in cell adhesion phenomena) drive ex-
pression of the LacZ gene in an ependym in-specific manner in
zebrafish embryos. Similarly, heterologous regulatory se-
quences from the rat GAP-43 gene (which codes for a major
component of the neuronal growth cones) driving the LacZ gene
were specifically activated in the embryonic nervous system
(Reinhard et al., 1994). Thus, as the proximal promoter region
was sufficient to confer pituitary-specific expression on the
tiGH promoter in cell lines, we extended our study to microin-
jected zebrafish embryos. We observed that the proximal re-
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FIG. 6. Activation mediated by the Pit-1 site tiGHF1 to a het-
erologous promoter. Two copies of the tiGHF1 site were cloned
upstream  from the heterologous Tk promoter (2xtiGHF1-Tk-
Luc), and the transcriptional activity was compared with that
of the parental Tk-Luc construct. Values are the means 6 SE
from three independent transfection experiments performed in
duplicate.
FIG. 7. Stimulation of tiGH proximal promoter activity by
rat Pit-1 in nonpituitary cells. Carp EPC cells were cotrans-
fected by the calcium  phosphate method with 2 pmoles of
p( 2 463/ 1 19)tiGH-Luc and 0.1, 0.5, 1, 2, or 4 m g of pRSV-
rPit-1 expression plasmid for rat Pit-1. The pRSV-CAT ex-
pression plasmid was used as a negative control, and a pCMV-
b gal (1 m g) was included to normalize the values for
transfection efficiency. After 52 h, luciferase and b -galactosi-
dase activities were measured. Results are the mean 6 SE of
four experiments, each performed in duplicate.
FIG. 8. b -Galactosidase activity in zebrafish embryos in-
jected with a tilapia mossam bica GH promoter directing b -
galactosidase expression. Embryos (1 to 2 cells) were injected
with p( 2 463/ 1 19)tiGH - b gal. After 24 h, the embryos were
fixed and incubated with X-Gal to visualize b -galactosidase ac-
tivity. A representative embryo is shown at 3 55 magnification.
The arrow indicates specific b -Gal expression. Blue cells were
identified on the basis of their location in spinal cord or brain.
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FIG . 9. Effect of downstream Pit-1-binding site tiGHF0 on transient Luc gene expression in GC cells. A . Reporter plasmids (4
pmoles) containing the tiGH promoter sequences ( 2 463/ 1 19), the wild type 2 463/ 1 40 region, or the 2 463/ 1 40 region mu-
tated in the potential downstream Pit-1-binding site ( 1 19/ 1 40) were transfected into GC cells or EPC cells transfected with the
pRSV-rPit-1 expression vector (B ; 1 ). In addition, 1 m g of pCMV- b gal was cotransfected as a control for transfection efficiency.
After 2 days, luciferase activities were determined and normalized to the b -galactosidase activity. Values are the means 6 SE
of duplicate experiments performed at least twice.
FIG . 10. Gel-shift analysis of the hGHF1 and tiGHF0 oligonucleotides. A . End-labeled hGHF1, corresponding to the first Pit-
1-binding site of the human GH promoter, and tiGHF0, which contains the Pit-1 site localized in the 5 9 -UTR, were incubated
with GC nuclear extract (3 m g). For competition experim ents, 200-fold molar excess of the unlabeled oligonucleotide hGHF1
(lanes 2 and 9), tiGHF0 (lanes 3 and 8), tiGHF0m (lanes 4 and 10), and AP-1 (lanes 5 and 11) were added to the reaction mix-
ture. Supershift assays were perform ed using 1 m l of crude antiserum raised against the N-terminal part of the human Pit-1 pro-
tein (lanes 6 and 12). B . End-labeled tiGHF0 was incubated in the absence (lane 1) or presence (lanes 2 and 3) of 3 m g of GC
nuclear extract, 15 m g of tilapia pituitary nuclear extract (lanes 4 and 5), or 15 m g of trout pituitary nuclear extract (lanes 5 and
6). Competitions were performed using a 200-fold molar excess of unlabeled hGHF1 (lanes 3, 5, and 7).
A B
gion of the tiGH promoter is sufficient to direct expression
specifically to the developing nervous system , in particular to
the area at the midbrain±hindbrain boundary. This expression
correlates well with the first, early phase of Pit-1 (and other
POU-homeodomain factor) expression in neural tissue during
rat development (He et al., 1989). We did not detect specific
expression of the transgene in the pituitary using this approach,
probably because of the mosaic distribution and dilution of the
injected DNA in the embryos. Note that in some embryos, there
was an intense expression in the yolk sac endoderm . This ec-
topic high-level transgene expression was probably attributable
to the differential replication of transgene copies in multinu-
cleated or polyploid tissues such as the yolk syncytial layer
(Williams et al., 1996).
In the rat, Pit-1 autoregulates its own expression by binding
to two sites. The first one, named PitB1, is located in the pro-
moter and mediates strong stimulation of transcription, whereas
occupancy of the PitB2 site, located just downstream of the
transcription initiation site, results in attenuation of the stimu-
latory effects of PitB1, reflecting either decreased efficiency of
transcriptional initiation or attenuation of nascent transcripts
(Chen et al., 1990). Smith and Sharp (1991) demonstrated in
vitro that Pit-1 interaction with the downstream site represses
the activity of the Pit-1 gene by blocking the elongation by
RNA polymerase II through the occupied binding site. Cis-act-
ing interactions of this type might also regulate elongation dur-
ing tiGH gene transcription, as several potential binding sites
for Pit-1 were found within the structural part of this gene. The
most interesting one is located in the 5 9 -UTR, as it appears to
be somewhat similar to the PitB2 site found in the 5 9 -UTR of
the rat Pit-1 gene. Indeed, when the 1 19/ 1 40 sequence, en-
compassing the potential Pit-1-binding site (tiGHF0), was ei-
ther deleted or mutated, a fourfold increase in expression of
p( 2 463/ 1 40)tiGH-Luc was observed. The EMSA experiments,
using the potential downstream Pit-1-binding site tiGHF0 as a
probe, clearly showed that Pit-1 specifically binds to this site.
This effect was independent of the presence of serum and was
also obtained in EPC cells cotransfected with a rat Pit-1-ex-
pression vector.
Thus, our results indicate that the single Pit-1-binding site
downstream of the transcription start site negatively regulates
expression of the tiGH gene. The mechanism for this repres-
sion could be similar to the one shown for the rat Pit-1 gene.
However, we cannot rule out the possibility that binding to the
Pit-1 site in the tiGH gene inhibits transcription by sterically
interfering with the formation of the transcription initiation
complex. A similar role for other putative Pit-1 sites in the tran-
scribed region remains to be established, but our observations
and the fact that such sites are absent in mammalian GH genes
raise the possibility of a more refined regulation of the tran-
scription of this gene in lower vertebrates. This is the first time,
except for the negative feedback regulation of Pit-1 itself, that
repression by Pit-1 of a gene specifically expressed in the pi-
tuitary has been observed.
The ability of rat Pit-1 to interact with the downstream con-
sensus sequence in the 5 9 -UTR of the tiGH gene suggests the
occurrence of a Pit-1 homolog in tilapia. In the presence of
tilapia pituitary nuclear extracts, we observed specific com-
plexes with the tiGHF0 oligonucleotide. These complexes cor-
respond to the binding of a monomer (tiCb) or a dimer (tiCc)
of a tilapia Pit-1-like factor. Fish (chum salmon and rainbow
trout) cDNAs encoding the Pit-1 factor have been cloned (Ono
and Takayam a, 1992; Yamada et al., 1993). The salmonid Pit-
1 proteins are larger than rat Pit-1, as they contain two inser-
tions of about 30 aa each in their N-terminal part. This explains
why the complexes obtained with trout pituitary extracts mi-
grated more slowly than those observed with rat GC cell ex-
tracts in EMSA experiments. Interestingly, the protein±DNA
complexes observed using the tilapia pituitary extracts migrate
to the same position as those observed using trout pituitary ex-
tracts, suggesting that the tilapia Pit-1 might be of a size simi-
lar to that of the other characterized fish Pit-1.
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